Zynerba Pharmaceuticals Announces Presentation of Phase 2 BELIEVE Safety\, Efficacy and Quality of Life Data in Developmental and Epileptic Encephalopathies (DEE) at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session